Coronary artery disease in asymptomatic type-2 diabetic women: a comparative study between exercise test, cardiopulmonary exercise test, and dipyridamole myocardial perfusion scintigraphy in the identification of ischemia by Smanio, Paola Emanuela Poggio et al.
Original Article
Coronary Artery Disease in Asymptomatic Type-2 Diabetic Women. A 
Comparative Study between Exercise Test, Cardiopulmonary Exercise 
Test, and Dipyridamole Myocardial Perfusion Scintigraphy in the 
Identification of Ischemia
Paola Emanuela Poggio Smanio, Antonio Carlos Carvalho, Antonio Sergio Tebexreni, Anneliese Thom, Filadelfo 
Rodrigues, Romeu Meneghelo, Luiz Mastrocolla, Alexandre Alves, Leopoldo Soares Piegas, Angelo Amato de Paola 
Instituto Dante Pazzanese de Cardiologia – Universidade Federal de São Paulo, São Paulo, SP – Brazil
Summary
Background: Cardiovascular disease is the leading cause of morbidity and mortality among diabetic individuals. 
Myocardial ischemia is frequently asymptomatic, thus leading to a late diagnosis and worse prognosis. Diabetic women 
are known to have a cardiovascular death risk higher than that in men. 
Objectives: To assess the prevalence of coronary artery disease (CAD) in asymptomatic diabetic women. To compare the 
results of exercise test (ET), cardiopulmonary exercise test (CPET), and dipyridamole myocardial perfusion scintigraphy 
(MPS) with the findings of coronary angiography, (ANGI) in order of identify the most accurate method in the detection 
of significant CAD. 
Methods: A total of 104 diabetic women were assessed with ET, CPET and MPS in the period within two months from the 
ANGI. MIBI-99mTc scintigraphy was performed using the gated-SPECT technique. Pearson’s chi-square, Student’s t tests 
were used for the statistical analysis and also the logistic regression analysis.
Results: The prevalence of CAD in the group studied was 32.7%. For the ET, an effective test (p=0.045), the chronotropic 
incompetence (p=0.031), and the exercise time performed (p=0.022) showed a significant association with DAC. For 
CPET, peak VO2 and HR achieved were associated with CAD (p=0.004 and p=0.025, respectively). Most of the MPS 
variables showed a significant association with CAD (p=0.001, for all).
Conclusions: The results obtained may suggest a high prevalence of CAD in diabetic women. Thus, this population 
should be investigated from the cardiovascular point of view even without cardiac symptom. Of the noninvasive 
diagnostic methods used, dipyridamole MPS was the one that showed the highest discrimination power in relation to 
diabetic women with CAD. (Arq Bras Cardiol 2007;88(5):263-269)
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Introduction
The prevalence of diabetes mellitus (DM) has been 
growing fast and continuously in the past decades, thus 
acquiring epidemic proportions1. Paradoxically to the 
reduction in coronary artery disease (CAD) mortality, diabetic 
individuals have presented a significant increase in mortality1. 
Cardiovascular disease is the leading cause of morbidity and 
mortality, affecting approximately half of the diabetic patients1. 
In this group of patients, myocardial ischemia is frequently 
silent, thus leading to a late diagnosis and worse prognosis1.
Since the 1990’s, studies2-4 have demonstrated differences 
in the investigation of CAD according to the patient’s gender, 
and these differences have been attributed to the lower 
incidence and atypical symptoms among females. However, 
diabetic women are known to have a cardiovascular death 
risk 7.5 times higher than non-diabetic women18. Since the 
presence of cardiovascular events (CE) may be modified by 
an appropriate screening and adequate intervention and 
treatment, early diagnosis may be of great benefit. 
The objective of the present study is to assess the 
prevalence of CAD among type-2 diabetic women without 
cardiovascular symptoms and also to identify the most 
effective diagnostic method to detect significant CAD in the 
group mentioned, by comparing the findings of exercise test 
(ET), cardiopulmonary exercise test (CPET), and dipyridamole 
(DIPY) myocardial perfusion scintigraphy (MPS) with those of 
coronary angiography (ANGI).
Methods
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Initially, 120 type-2 diabetic women aged between 40 and 
80 years and diagnosed with DM for at least five years were 
included. Women with functional limitation or symptoms 
suggestive of ischemia were excluded. The patients were 
recruited (after study approval by the institution’s ethics and 
research committee) via telephone call or mail and were 
included in the study after a baseline interview, clinical 
evaluation, and signature of the informed consent form. 
After the interview, 16 patients were excluded (because of 
symptoms suggestive of ischemia or difficulty to attend follow-
up appointments to undergo tests). A total of 104 patients 
remained in the study and had their glycosylated hemoglobin 
(Hb1Ac), ET, CPET, MPS, and ANGI performed with a maximum 
2-month interval and with no revascularization procedures 
between the tests. According to previous recommendation, 
medications that could interfere with the analysis of the 
diagnostic tests were discontinued. The tests were analyzed 
by two specialists in each area, and they had no information 
on the results of the other tests.
Glycosylated hemoglobin determination - This determination 
was performed in our institution, using the automated 
immunoturbidimetric method (Roche™). Values ranging from 
4.8 to 6.0 units were considered normal. 
Coronary angiography - The coronary arteries were 
analyzed as regards the degree of stenosis using both visual 
and quantitative analysis and the percentage of stenosis was 
calculated automatically by a standard formula. Obstructions 
≥ 50% were considered as significant CAD. Detection of 
collateral circulation (CC) was only considered relevant as a 
justification for the discrepancies between ANGI and the other 
methods, as well as to verify associations with ST-segment 
alterations during DIPY. 
Exercise test - The protocol used was the already 
standardized modified Bruce protocol5. The variables 
determined in the ET and later compared with ANGIO were: 
exercise time (∆t), blood pressure (BP) behavior, ST-segment 
analysis, presence of typical exercise-induced chest pain 
(CP), and presence of chronotropic incompetence (CI) or of 
complex exercise-induced arrhythmias.
The ET was interpreted, according to the presence of 
electrocardiographic and clinical alterations, as suggestive 
of ischemia in the presence of ST-segment depression (ST-
depression) ≥ 1.5 mm in relation to baseline or CP suggestive 
of exercise-induced ischemia. Also, it was interpreted as 
abnormal (anl) if complex exercise-induce arrhythmias, 
abnormal behavior of BP (drop or systolic BP plateau) and of 
heart rate (inappropriate elevation of heart rate in response 
to exercise in the absence of medications) were found. The 
presence of ventricular extrasystoles, whether paired or 
in salvos, or of nonsustained exercise-induced ventricular 
tachycardia was considered a complex arrhythmia. The 
presence of exercise-induced decrease in systolic BP ≥10 
mmHg or maintenance of BP with increasing effort was 
considered BP decrease and plateau behavior, respectively. 
The inappropriate elevation of heart rate (HR) was considered 
abnormal and called CI, and was assessed by the formula 
previously described by Azarbal6. 
Cardiopulmonary exercise test - The following variables 
were analyzed and compared to the results of ANGI: maximum 
oxygen consumption (VO2max) or oxygen consumption at 
exercise peak (VO2peak), anaerobic threshold (AT), oxygen 
pulse (VO2peak pulse) and drop in O2 pulse (DPO2) at exercise 
peak. The other variables determined by CPET, such as HR 
behavior, exercise time, and ST-segment analysis followed the 
same criteria described for the ET.
Dipyridamole myocardial perfusion scintigraphy - MPS with 
DIPY and in baseline conditions was performed with MIBI-
99mTc according to the two-day standard protocol. Images were 
acquired using the gated-SPECT technique7. Dipyridamole 
was injected at a dose of 0.56 mg/kg/min in four minutes 
(min). A total of 20 miliCuries (mCi) or 740 megaBecquerel 
(MBq) of MIBI-99mTc were administered in the second minute 
after DIPY infusion, which was considered the time point of 
maximal hyperemia. The images were acquired 60 min after 
the radiopharmaceutical was injected. ECGs were performed 
before, during, and for six minutes after the end of DIPY 
infusion. DIPY-MPS was considered suggestive of ischemia if 
ST-depression or intensification of ST-depression ≥ 1.0 mm; 
ST-elevation ≥ 1.0 mm; or clinical manifestations suggestive of 
ischemia were found8. The adverse effects that occurred during 
the administration of dipyridamole were readily reverted with 
the use of endovenous aminophylline. The baseline phase was 
performed between 24 – 72 hours after the DIPY phase. 
The images were processed by the QGS software 
program7,9. Gated-SPECT provided a reproduction of 
cardiac wall contractility, end-systolic and diastolic volume 
indexes (ESV and EDV, respectively), and left ventricular 
ejection fraction (LVEF) index. Qualitative assessment of the 
radiopharmaceutical concentration in 17 myocardial segments 
was used to analyze the perfusion images. According to 
the homogeneity, or lack of homogeneity, of uptake in the 
myocardial segments, MPS were considered as: normal, if the 
indicator concentration was homogeneous in both phases; 
suggestive of ischemia, if there was a reversible low indicator 
uptake in one or more myocardial segments after stress; 
suggestive of fibrosis if there was a fixed low uptake in one 
or more segments in both phases; and suggestive of ischemia 
and fibrosis if there was fixed and reversible low uptake in 
one or more segments in both phases.
The analysis of left ventricular (LV) systolic function was 
based on information from the gated-SPECT. The variables 
obtained were: wall contractility (normal or abnormal); 
systolic wall thickening (normal or abnormal), and dilation in 
the stress and baseline phases. The presence of LV dilation 
was analyzed by taking into consideration the ESV and EDV 
recommended in the literature. In the QGS software program 
analysis, ESV equal to 84+/- 26 ml and EDV equal to 33+/-
17 ml were considered normal9. Also, the presence of cavity 
dilation in the stress phase was analyzed in comparison 
with basal one (transient LV dilation), using visual analysis 
and the TID (transient ischemic dilation) index, with values 
higher than 1.22 representing significant dilation10,11. Other 
variables obtained were the presence of abnormal pulmonary 
radionuclide uptake12; LVEF in the post-DIPY and baseline 
phases, with values ≥ 50% being considered normal for the 
QGS software program; and the presence of a > 5% decrease 
in LVEF values in the exercise phase in relation to baseline.
Statistical analysis - The Pearson’s chi square test was 
used to compare the patient groups in relation to categorical 
variables, and the Student’s t test was used in relation to 
numeric variables for non-related samples. Discriminant 
analysis was used to differentiate women with significant 
CAD. Logistic regression analysis was also performed. P values 
<0.05 were considered significant. Interobserver agreement 
for each method was assessed using the kappa statistics 
(categorical variables), and intraclass correlation coefficient 
(numeric variables). 
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Results:
After the statistical analysis, a 32.7% prevalence of 
significant CAD was observed among diabetic women with 
no cardiovascular symptoms. Of the 104 patients studied, 34 
had a ≥ 50% stenosis.
Coronary angiography - Of the 34 patients with significant 
stenosis as analyzed by quantitative ANGI, 22 had 1-vessel 
disease; seven had two-vessel disease; and five had three-
vessel disease. The anterior descending artery was affected in 
13 patients; the right coronary in 18 patients; the circumflex in 
8; the diagonal artery in 3; the marginal branch in one patient; 
and the ventricular posterior branch in two patients.  No 
patient presented lesions in the left main coronary artery.
Clinical variables - No clinical characteristic enabled 
discrimination of patients with CAD using the univariate 
analysis, as shown in Table 1. Using the multivariate logistic 
regression analysis (Table 2), the variables predictive of CAD 
were smoking (0.002), and abnormal Hb1Ac values (0.041).
Noninvasive diagnostic methods - Interobserver agreement 
for the presence of ischemia on ET was high (κ = 0.787). For 
CPET, interobserver agreement was also high in relation to 
VO2max (ρ = 0.974), ventilatory AT (ρ=0.900) and O2 pulse 
(ρ = 0.867) determinations. The agreement for determination 
of DPO2 was low (κ= 0.426). Interobserver agreement for 
MPS in relation to the presence of perfusion alterations was 
high (κ= 0.810) and the agreement between qualitative and 
quantitative analysis of ANGIO in relation to the presence of 
CAD was also  high (κ= 0.833).
Variables of the exercise test - Values of sensitivity (SE), 
specificity (SP), positive predictive value (PPV), negative 
predictive value (NPV), positive likelihood ratio (LR+), 
negative likelihood ratio (LR-), and accuracy (A) found for 
the ET were 44.1%; 61.4%; 35.7%; 69.3%; 73%; 71.3% and 
55.7%, respectively. The ET variables that were associated with 
CAD were: effective test (p=0.045), CI (p=0.031), exercise 
time (p=0.022) and maximum HR achieved (p=0.027), as 
shown in Table 3.
Cardiopulmonary exercise test variables - The variables that 
were associated with CAD were VO2 peak (p= 0.004) and 
maximum heart rate achieved (p=0.025), as shown in Table 4. 
Values of SE, SP, PPV, NPV, LR+, LR-, and A found for CPET in 
relation to the diagnosis of CAD were 44.1%, 72.8%, 44.1%, 
72.8%, 61.4%, 59.2% and 63.4%, respectively.
Scintigraphy variables - Most of the DIPY-MPS variables 
showed an association with the presence of CAD (Table 5). 
The presence of ischemia and fibrosis showed a significant 
association (p=0.001 for both). No significant association 
was observed between the presence of CC and ST-depression 
during DIPY infusion (p = 0.467). Of the nine patients who 
presented ST-depression during DIPY infusion, four (44.4%) 
had significant CC. Also, no association was observed between 
the presence of ST-depression and CAD (p = 0.053). The 
values of SE, SP, PPV, NPV, LR+, LR- , and A found for DIPY-
MPS in the diagnosis of CAD were 94%; 97%; 94%; 97%; 
98%; 95.8% and 96.1%, respectively. During DIPY infusion, 
no severe side effects such as death or MI were observed 
in the population studied. We observed that: 21 patients 
(20.1%) had CP; 9 (8.6%) had ST-depression; 14 (13.4%) had 
headache; 18 (17.3%) had dizziness; 4 (3.8%) had nausea; 
2 (1.9%) had complex ventricular arrhythmias; 6 (5.7%) 
had facial rash; 2 (1.9%) had hypotension and 4 (3.8%) had 
shortness of breath.
Discussion
The high prevalence of CAD found in the group studied 
(32.7%) may be explained by the particular characteristic of 
our Institution. Given that it is one of the cardiology referral 
centers in the State of Sao Paulo, it serves a large number of 
patients with multiple risk factors for CAD, thus characterizing 
a population with a high pretest probability (Table 1).
According to the consensus published in 1988 by the 
American Diabetes Association1, the estimated prevalence of 
CAD for patients with DM is of 55%. 
No studies demonstrating the prevalence of CAD, 
specifically among women with type-2 DM with no 
cardiovascular symptoms, are available in the literature. 
No clinical and epidemiological characteristic showed 
a significant association with CAD in the group studied 
using univariate analysis. Using logistic regression analysis, 
however, abnormal Hb1Ac values and smoking were factors 
discriminating patients with CAD in this population (Table 
2). 
The first challenge in the diagnosis of CAD in diabetic 
women is to determine the best method for an initial 
screening. 
Traditional resting ECG adds little information in the 
identification of patients with CAD, since it only rules out 
or suggests the presence of acute CE or previous myocardial 
infarction (MI)13. Baseline ECG in women frequently shows 
ventricular repolarization abnormalities (VRA), thus making it 
hardly relevant in the diagnosis of CAD13. In premenopause, 
ECG specificity is known to be even lower because estrogen-
related VRA are more frequent, and estrogen is considered 
responsible for vasoconstriction of the coronary network, thus 
resulting in the abnormalities mentioned13. VRA are restricted 
to the ST-segment and the T wave, and are similar to those 
observed during the use of digitalis, which has molecules 
structurally similar to those of estrogen13. Of the 104 patients 
evaluated, 39 (37.5%) presented VRA on baseline ECG.
ET is largely used as the method of choice in the initial 
investigation of CAD; according to the literature, it has 
sensitivity (SE) and specificity (SP) values lower in females 
than in males (approximately 61% and 69%, respectively)5,8. 
As previously mentioned, we found lower values in the 
present study. 
Diabetic women also frequently have peripheral vascular 
insufficiency1. In the group studied, 43 patients (42%) had an 
ineffective ET, which may be one of the reasons for the low 
SE found. Another limitation was the large number of tests 
considered “falsely” suggestive of ischemia because of the 
VRA. Henzlova et al13 compared three groups of women who 
had undergone MPS after exercise. Although the MPS had 
been normal, the patients that were on hormone replacement 
therapy had 39% of ET compatible with ischemia, in 
comparison with 22% in the premenopausal group, and 17% 
in the postmenopausal group, both not receiving estrogens. 
Of the 39 patients (37.5%) who had a baseline ECG with 
VRA in the group studied, 10 (33.3%) had ET suggestive of 
ischemia in the absence of significant CAD, which probably 
made SP low.
Exercise time (∆t) may indirectly reflect the patients’ 
functional capacity5,8. In the group studied, despite the lower 
limb limitation and low ∆t, a significant association was 
observed between ∆t and the presence of CAD (p=0.022). 
The heart rate achieved was also associated with CAD. In the 
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group of patients with CAD, HR was, on average, equal to 
132.45 bpm, and in the patients without CAD, it was equal 
to 142.07 bpm, with p=0.027 (Table 3). 
HR is known to increase linearly during dynamic exercise 
according to the increase in the workload and O2 consumption. 
A higher HR elevation is usually observed among females in 
relation to males5, and it is known that an inadequate increase 
in HR may be an important sign of CAD. Azarbal et al6 verified 
that CI is an important predictor of mortality and should be 
incorporated in risk stratification algorithms of ET. However, 
the authors described that MPS was a better predictor of 
mortality and of CE in relation to the presence of CI. In the 
present study, a significant association was observed between 
CI and CAD (p=0.031). Of the 34 patients with significant 
CAD, 26 (73.5%) showed criteria of CI.  
As previously mentioned, CPET may provide valuable 
information on functional capacity. In this study, we attempted 
to assess the value of CPET in the diagnosis of CAD in 
asymptomatic diabetic women. Because of the lower cost in 
relation to MPS and of the possibility of association of ECG 
and clinical variables obtained with exercise with functional 
parameters, CPET is perhaps a noninvasive diagnostic 
method with a higher cost-effectiveness ratio than ET and 
DIPY-MPS. 
Few studies on the usefulness of CPET in the investigation of 
CAD have been published14,15. Klainman et al14 demonstrated 
Table 1 – Clinical and epidemiological characteristics of the groups with and without CAD on ANGI. HBP: high blood pressure; Hb1Ac: glycosylated 
hemoglobin; anl: abnormal; SD: standard deviation 
without DAC (70) WITH DAC (34) p
Mean age (SD) 59.18 (9.97) 59.79(8.79) 0.542
Mean Hb1Ac (SD) 6.76(2.19) 7.17(1.92) 0.345
HBP 70 (67.3%) 34 (32.7%) ---
Smoking 17(24%) 13(38%) 0.141
Dyslipidemia 61(87%) 31(91%) 0.546
Obesity 59(84%) 26(76%) 0.333
Sedentary lifestyle 64(91%) 32(94%) 0.721
Family history 45(64%) 21(62%) 0.802
Anl Hb1Ac 37(53%) 21(62%) 0.391
Menopause 56(80%) 24(70%) 0.130
Table 2: Logistic regression analysis of the clinical and epidemiologic characteristics. Anl Hb1Ac: abnormal glycosylated hemoglobin; OR: odds ratio
Coefficient Standard error p O.R.
Anl Hb1Ac 1.236 0.604 0.041 3.443
Smoking 3.118 1.018 0.002 22.610
Family history 0.896 0.634 0.158 2.449
Obesity -0.869 0.592 0.142 0.419
Table 3- Exercise test variables in the groups of patients with and without CAD. Anl BP: abnormal blood pressure behavior at exercise; CI: chronotropic 
incompetence; HR max: maximum heart rate achieved with exercise; SD: standard deviation
Without CAD (70) WITH CAD (34) p
Ischemia 27(38%) 15(44%) 0.589
Chest pain 16(23%) 14(41%) 0.053
Efficient 46(66%) 14(41%) 0.045
Anl BP 35(50%) 15(44%) 0.573
Complex arrhythmia 20(28%) 12(35%) 0.486
CI 37(53%) 26(76%) 0.031
Exercise time (SD) 7.53(2.56) 6.27(2.70) 0.022
HR max- mean (SD) 142.07(20.38) 132.45(20.43) 0.027
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that ventilatory variables are decreased with exercise when 
healthy patients are compared to those with CAD. In the 
present study, peak VO2 and HR achieved with exercise were 
observed to be associated with the presence of CAD (p=0.004 
and p=0.025, respectively).   The SE value found for CPET in 
the diagnosis of CAD was also low: equal to 44.1%. The SP 
value, in turn, was higher than that of ET (72.8%). Of the 34 
patients with CAD on ANGI, only 15 had a CPET suggestive 
of ischemia. On the other hand, of the 70 patients without 
significant CAD, 51 had a CPET not suggestive of ischemia 
at exercise. 
The identification of severity and extent of perfusion defects 
enables the degree of functional consequences of a coronary 
stenosis to be established. Since not always does an anatomical 
coronary artery lesion produce ischemic alterations, there 
are situations in which a joint anatomical and functional 
investigation would be the most appropriate management.
In addition to the importance in risk stratification and 
clinical management, MPS is considered an important 
noninvasive method that adds diagnostic accuracy to ET for 
both genders16,17. Its high SP is particularly useful to identify 
women with ET considered “false negative”8. The mean SE 
and SP values for planar thallium-201-MPS are 84% and 
87%, respectively, and for SPECT-MPS, the mean SE increases 
to 88%, without decreasing SP (87%). With the advances 
in methodology, there were increases in SE and SP values. 
Smanio et al found SE and SP values of 95% and 94.1%, 
respectively, using the gated-SPECT technique18.
To date, a small number of studies on MPS in women is 
found in the literature. Taillefer et al19 compared thallium-
201 to MIBI-99mTc in 115 women and found no significant 
difference in SE between the two radiopharmaceuticals19. 
However, there was a great increase in SP with the gated-
SPECT technique (92% vs. 67%, respectively).
Previous studies20,21 found similar values for DIPY and 
adenosine testing in relation to the images obtained after 
Table 4- CPET variables in the groups of patients with and without CAD. DPO2: drop in oxygen saturation during exercise; ECG: electrocardiogram; 
VO2 peak: maximum oxygen consumption at exercise peak; AT: anaerobic threshold; HR: heart rate
WITHOUT CAD (70) WITH CAD (34) p
 DPO2 26(37%) 8(23%) 0.360
Ischemia on ECG 19(27%) 15(44%) 0.292
VO2peak- mean (SD) 16.41(4.57) 13.59(3.55) 0.004
O2 SATURATION  - mean (SD) 8.24 (2.35) 8.00(2.06) 0.626
AT-  mean  (SD) 11.75(3.61) 11.71(3.58) 0.953
Exercise time -mean (SD) 9.02(2.36) 8.54(2.94) 0.417
HR max - mean (SD) 142.21(20.75) 130.85(20.19) 0.025
Table 5: Scintigraphy variables in the groups of patients with and without CAD. LV: left ventricle; ECG ischemia: ECG during DIPY suggestive of 
ischemia; SD: standard deviation; TID: transitory ischemic dilation; LVEF: left ventricular ejection fraction; ESV: end-systolic volume; EDV: end-
diastolic volume
Without CAD WITH CA D p
Ischemia 2 28 0.001
Fibrosis 3 13 0.001
Abnormal perfusion 4 32 0.001
LV dilation 15 15 0.017
TID 4 11 0.001
Pulmonary uptake 0 4 0.003
Drop in LVEF 29 16 0.651
Abnormal thickening 10 26 0.001
Abnormal contractility 18 25 0.001
ECG ischemia 3 6 0.053
Chest pain during infusion 12 9 0.166
LVEF post- DIPY –mean (SD) 0.59(0.13) 0.47(0.15) 0.001
Baseline LVEF – mean (SD) 0.60 (0.12) 0.50(0.14) 0.001
ESV – mean (SD) 38.51(29.15) 61.44(48.16) 0.001
EDV – mean (SD) 83.34(34.72) 107.59(49.08) 0.001
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exercise. Verani et al20 confirmed the superiority of DIPY-MPS 
in relation to submaximal ET in the diagnosis of CAD. Because 
of the low functional capacity found in the group studied (43% 
of ineffective ET), an important investigation was made using 
a method that did not require strenuous effort and had a high 
diagnostic power, such as the DIPY-MPS.
Few studies20,25 verified the value of MPS in asymptomatic 
diabetic patients. For this purpose, the multicenter DIAD 
study (Detection of Ischemia in Asymptomatic Diabetics) 
enrolled patients from 14 American and Canadian centers26, 
and found 22% of ischemia in asymptomatic type-2 diabetic 
subjects. Rajagopalan et al25 found 826 patients (58%) with 
ischemia among 1427 asymptomatic diabetics. Prior et al24 
and Lerner et al27 identified perfusion defects in 37% of the 
133 asymptomatic diabetic individuals (of both genders) 
who underwent MPS. Of these, 30% were reversible, thus 
suggesting ischemia. 
In this study, SE and SP values of MPS in the diagnosis of 
CAD were high (94% and 97%, respectively), and similar to 
those described in the literature16. Most of the MPS variables 
were associated with CAD (Table 5). Of the 34 patients with 
significant lesion on ANGI, only two (1.9%) were not identified 
by MPS; both showed preserved perfusion and contractility. 
The lesions were probably not functionally significant. Of the 
70 patients without CAD on ANGI, 68 had normal MPS. 
Functional information is also useful in the diagnosis and 
prognosis of CAD16, 28. In this study, we verified that baseline 
and post-DIPY LVEF values showed association with CAD 
(p=0.001 for both). However, the LVEF decrease after DIPY 
in relation to baseline did not show a significant association 
with CAD (p=0.651). 
Yamagishi et al’s study28 demonstrated that the decrease 
in LVEF values after stress promotes an increase in SE for the 
detection of multivessel disease. We can try to explain this 
discrepancy of the literature by the presence of alterations 
in microcirculation that are common in diabetics and which 
can cause subendocardial ischemia and drop in LVEF during 
pharmacological testing in the absence of an anatomically 
severe obstructive lesion. 
Systolic thickening and contractility alterations also showed 
a significant association with CAD (p = 0.001). The presence 
of LV dilation and pulmonary MIBI uptake in the stress phase 
were also verified to be associated with CAD (p = 0.017 and 
p = 0.003, respectively). In patients with resting or stress-
induced LV dysfunction there can be a radiopharmaceutical 
extravasation into the pulmonary interstitial space due to 
the increase in end-diastolic pressure12. Additionally, with 
the prolonged circulatory time, increased radioactivity is 
observed in the lung fields. Although this phenomenon is 
more frequent in thallium-201 MPS, it can also be observed 
with Mibi-99mTc.
Another variable analyzed was transient left ventricular 
dilation (TID) after dipyridamole infusion. The presence of TID 
after the stress phase is usually related to LV failure and has 
a strong association with CAD with stress-induced ischemic 
dysfunction, which has an unquestionable predictive value in 
the determination of survival11. Hansen et al12 studied 1129 
patients and verified a significant association between the 
presence of TID after DIPY infusion and CAD12, and attributed 
this ventricular cavity dilation to a diffuse subendocardial 
hypoperfusion. In the group studied, a significant association 
was observed between the presence of TID and CAD (p = 
0.001). 
When clinical and electrocardiographic variables during 
DIPY infusion were analyzed, CP and ECG alterations were 
observed not to have a significant association with CAD (p = 
0.166 and 0.053, respectively). ST-depression during DIPY 
infusion may be secondary to the “flow steal” phenomenon20. 
However, no association between ST-depression and 
significant CC on ANGI was observed in this group either (p 
= 0.467).
The method proved safe and the side effects presented 
were similar to those described in the literature21. 
Study limitations and clinical implications
The qualitative analysis of the perfusion images was a study 
limitation. The interpretation using quantitative analysis by 
scores described in the literature is neither routinely used 
in our service nor in most of the clinical nuclear medicine 
services. Therefore, it would not make sense to investigate 
CAD with a methodology that is not actually used in daily 
clinical practice.
Finally, we understand that this study is of great value in 
the clinical management of diabetic women. Knowing that the 
cardiovascular risk is high in patients with DM, and that women 
have clinical manifestations which are difficult to characterize, 
preventive cardiovascular assessment is warranted in the 
group studied. The presence of VRA on baseline ECG leads 
to lower accuracy of exercise tests in the identification of 
CAD. In addition to the frequently observed low functional 
capacity in diabetic women, the value of methods that depend 
on the performance of strenuous exercise is limited. On the 
other hand, it is not cost-effective to perform an anatomical 
investigation in all diabetic women. 
As a consequence of the arguments shown, we can 
presume that performing a safe technique that has a high 
diagnostic and prognostic power, such as MPS associated 
with pharmacological testing with dipyridamole, may be the 
method of choice in the initial assessment of diabetic women, 
even in the absence of cardiovascular symptoms. 
As a primary conclusion, the results obtained showed 
that the prevalence of CAD in diabetic women with no 
cardiovascular symptoms is high (32.7%), and this population 
should be investigated from the cardiovascular point of view. 
Also, we conclude that the noninvasive diagnostic method 
that showed the highest power to discriminate women with 
CAD was DIPY-MPS; thus, this should be the gold standard 
method for this group of patients. 
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